Augurex Overview
- Founded
- 2007
- Status
- Private
- Employees
- 10
- Latest Deal Type
- Later Stage VC
- Investors
- 3
Augurex General Information
Description
Developer of bio-marker blood tests designed to transform patient clinical management for better disease outcomes. The company's bio-marker blood tests are based on point-of-care proprietary blood testing that connects with disease-specific applications and electronic health records, enabling doctors to optimize patient management by personalizing clinical decision-making.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
- 887 Great Northern Way
- Suite 220
- Vancouver, British Columbia V5T 4T5
- Canada
+1 (604) 000-0000
Augurex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 25-Jan-2017 | 00000 | Completed | Generating Revenue | ||
| 4. Angel (individual) | 01-Feb-2011 | 000.00 | 00000 | Completed | Startup | |
| 3. Angel (individual) | 01-May-2009 | 000.00 | 000.00 | Completed | Startup | |
| 2. Angel (individual) | 01-Nov-2007 | $52.8K | $52.8K | Completed | Startup | |
| 1. Grant | 01-Jan-2007 | $52.8K | Completed | Startup |
Augurex Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-marker blood tests designed to transform patient clinical management for better disease outcomes. The c
Diagnostic Equipment
Vancouver, Canada
10
As of 2020
00000
0000000000 0
00000
0000 000
eniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
000000000 00000 (0000000000)
Burlingame, CA
00
As of 0000
000.00
00000000000
000.00
00000000
citation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend
0000000000 000000000
Holytown, United Kingdom
0
As of 0000
000.00
00.00
0000-00-00
00000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAugurex Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Halo Labs | Venture Capital-Backed | Burlingame, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 000000000 | Venture Capital-Backed | Holytown, United Kingdom | 0 | 000.00 | 00000000000 | 000.00 |
| 00000000 | Accelerator/Incubator Backed | Toulouse, France | 0 | 0000000000 | ||
| 000000000 00000000 | Formerly VC-backed | Alpharetta, GA | 00 | 00000 | 000000 - 000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 000000000 | 00000 |
Augurex Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Norma Biln | Co-Founder & Chief Executive Officer | ||
| Natalie Dakers | Chairman |
Augurex Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Natalie Dakers | Self | Chairman | 000 0000 |
Augurex Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAugurex Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Genome British Columbia | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | |
| WUTIF Capital | Angel Group | Minority | 000 0000 | 000000 0 | |
| New Ventures BC | Accelerator/Incubator | 000 0000 | 000000 0 |